Wassum and Söderberg & Partners have merged and formed Wassum/Söderberg & Partners Institutional Advisors within the field of advice to institutional investors.
The board of directors of Hansa Medical has resolved on a directed new issue of shares, whereby Hansa Medical will raise proceeds of approximately SEK 453 / USD 50 million, before issue costs.
On 25 April 2017 the European Commission conducted dawnraids at the premises of Tele2 and three other mobile network operators active in Sweden regarding potential infringements of EU competition law.
Vinge has represented Adelis in connection with Presto Brandsäkerhet and Aptum joining forces to become the leading player in fire safety in the Nordic region with revenue of more than SEK 700 million.
Vinge has advised Irisity AB (publ), Nasdaq First North, in connection with a directed new issue of shares to Nordic institutional and private investors.
Vinge has advised Paradrestauranger AB in conjunction with the acquisition of Maincourse i Umeå AB which conducts the amusement park Rådhuset in Umeå which includes the popular Rex.
Vinge has advised Nordea Bank Abp (“Nordea”) in connection with Samhällsbyggnadsbolaget i Norden AB (publ) (”SBB”) tap issue of SEK 100 million hybrid bonds under the Company’s existing framework of up to SEK 1500 million.
William Hill has launched a recommended cash offer to the shareholders in Mr Green & Co, MRG (Nasdaq Stockholm). The total offer value for all shares in MRG amounts to approximately SEK 2.819 billion.
Galecto Biotech AB, the developer of galectin modulators for the treatment of severe diseases, including fibrosis and cancer, has closed a €79 million financing co-led by Ysios Capital and OrbiMed.
Vinge has advised Hexatronic Group AB (publ), listed on Nasdaq Stockholm mid‑cap, in connection with the acquisition of the entire share capital in the German fibre optic company Opternus GmbH.